Cervical Cancer Diagnostics and Therapeutics Market OCT2016 | Page 2

Global Cervical Cancer Diagnostics and Therapeutics Market According to the report " Global Cervical Cancer Diagnostics and Therapeutics Market ", published by Market Data Forecast, the global market is projected to reach USD 4.41 Billion by 2021, at a CAGR of 4.50% from 2016 to 2021. For full report refer to http://www.marketdataforecast.com/market-reports/global-cervicalcancer-diagnostics-and-therapeutics-market-829/ Cervical cancer is generally characterized by the abnormal growth of cancerous cells in the tissues of the cervix, and it may manifest itself as a squamous-cell carcinoma or adenocarcinoma. Cervical cancers and cervical pre-cancers are classified by how they look under a microscope. The first step in finding cervical cancer is often an abnormal Pap test result. This will lead to further tests which can diagnose cervical cancer. Free sample for the report is available at http://www.marketdataforecast.com/marketreports/global-cervical-cancer-diagnostics-and-therapeutics-market-829/request-sample Rising prevalence of cervical cancer, funding to increase disease awareness, and increasing consumer awareness are the main factors that are driving the market growth. Government support and enhanced healthcare infrastructure are providing opportunities for the manufacturers to enter this market as a good future potential is envisaged. Global market for Cervical Cancer Diagnostics and Therapeutics is segmented based on Type and Product into further sub-segments as follows: 1) By diagnostics test     Pap smear test HPV testing Colposcopy Cervical cancer biopsy 2) By methods    Molecular method Cytopathological method Physical method 3) By therapies     Surgery Radiation therapy Chemotherapy Other therapies 4) By end-users      Hospitals Laboratories Independent physicians Clinics Other end-users [phone] | www.marketdataforecast.com | [email protected]